GERON CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GERON CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $191.0K | Mar 16, 2018 |
| FY2017 | Sep 30, 2017 | $163.0K | Mar 16, 2018 |
| FY2017 | Jun 30, 2017 | $174.0K | Mar 16, 2018 |
| FY2017 | Mar 31, 2017 | $537.0K | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | $94.0K | Mar 16, 2018 |
| FY2017 | Sep 30, 2016 | $5.11M | Mar 16, 2018 |
| FY2017 | Jun 30, 2016 | $211.0K | Mar 16, 2018 |
| FY2017 | Mar 31, 2016 | $749.0K | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $220.0K | Mar 1, 2017 |
| FY2016 | Sep 30, 2015 | $35.36M | Mar 1, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $237.0K | Feb 28, 2024 |
| FY2023 | Dec 31, 2022 | $596.0K | Feb 28, 2024 |
| FY2023 | Dec 31, 2021 | $1.39M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $253.0K | Mar 16, 2023 |
| FY2019 | Dec 31, 2019 | $171.0K | Mar 12, 2020 |
| FY2019 | Sep 30, 2019 | $131.0K | Mar 12, 2020 |
| FY2019 | Jun 30, 2019 | $101.0K | Mar 12, 2020 |
| FY2019 | Mar 31, 2019 | $57.0K | Mar 12, 2020 |
| FY2019 | Dec 31, 2018 | $375.0K | Mar 12, 2020 |
| FY2019 | Sep 30, 2018 | $165.0K | Mar 12, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($83.50M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($174.57M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($184.13M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($141.90M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($116.11M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | ($75.62M) | Mar 16, 2023 |
| FY2019 | Dec 31, 2019 | ($29.07M) | Mar 12, 2020 |
| FY2019 | Sep 30, 2019 | ($15.18M) | Mar 12, 2020 |
| FY2019 | Jun 30, 2019 | ($14.24M) | Mar 12, 2020 |
| FY2019 | Mar 31, 2019 | ($10.06M) | Mar 12, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($68.59M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($173.73M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($193.94M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($138.55M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($114.00M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | ($76.91M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | ($72.51M) | Mar 10, 2022 |
| FY2020 | Dec 31, 2018 | ($31.07M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | ($29.26M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | ($30.65M) | Mar 7, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $159.26M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $145.73M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $69.14M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $43.63M | Feb 27, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($111.04M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($218.62M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($167.74M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($127.38M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($95.56M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | ($66.65M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | ($43.83M) | Mar 10, 2022 |
| FY2020 | Dec 31, 2018 | ($21.01M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | ($20.56M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | ($18.37M) | Mar 7, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $680.0K | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | $830.0K | Feb 27, 2025 |
| FY2024 | Dec 31, 2022 | $431.0K | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $207.0K | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $401.0K | Mar 16, 2023 |
| FY2021 | Dec 31, 2019 | $413.0K | Mar 10, 2022 |
| FY2020 | Dec 31, 2018 | $16.0K | Mar 11, 2021 |
| FY2018 | Dec 31, 2016 | $57.0K | Mar 7, 2019 |
| FY2017 | Dec 31, 2015 | $90.0K | Mar 16, 2018 |
| FY2016 | Dec 31, 2014 | $131.0K | Mar 1, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $570.54M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $593.78M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $394.08M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $190.58M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $226.03M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $270.73M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $165.52M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $185.28M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $110.31M | Mar 7, 2019 |
| FY2017 | Dec 31, 2016 | $130.25M | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $344.67M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $313.46M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $146.13M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $110.58M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $99.62M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $59.78M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $30.36M | Mar 11, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $225.87M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $280.32M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $247.95M | Mar 2, 2026 |
| FY2025 | Dec 31, 2022 | $80.00M | Mar 2, 2026 |
| FY2024 | Dec 31, 2021 | $126.42M | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | $210.95M | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | $135.16M | Mar 16, 2023 |
| FY2021 | Dec 31, 2018 | $177.73M | Mar 10, 2022 |
| FY2020 | Dec 31, 2017 | $103.80M | Mar 11, 2021 |
| FY2019 | Dec 31, 2016 | $122.38M | Mar 12, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.86B) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($1.77B) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($1.60B) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($1.41B) | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | ($1.27B) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($1.16B) | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | ($1.08B) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($1.01B) | Mar 12, 2020 |
| FY2018 | Jan 1, 2018 | ($984.45M) | Mar 7, 2019 |
| FY2018 | Dec 31, 2017 | ($985.84M) | Mar 7, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.56M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $79.02M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $70.02M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $56.85M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $34.87M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $9.93M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $13.64M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $10.58M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $16.34M | Mar 7, 2019 |
| FY2017 | Dec 31, 2016 | $12.81M | Mar 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | 0 | Mar 16, 2018 |
| FY2016 | Dec 31, 2014 | 0 | Mar 1, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 16, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | 0 | Mar 16, 2018 |
| FY2016 | Dec 31, 2014 | 0 | Mar 1, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 639.86M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 606.39M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 544.91M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 390.26M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 323.73M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | 310.57M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | 199.81M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 186.39M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 159.88M | Mar 7, 2019 |
| FY2017 | Dec 31, 2016 | 159.16M | Mar 16, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $0 | Mar 10, 2016 |
| FY2014 | Dec 31, 2014 | $0 | Mar 11, 2015 |
| FY2013 | Dec 31, 2013 | $0 | Mar 17, 2014 |